The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bohnsack, J. F.
Right arrow Articles by Zhou, X. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bohnsack, J. F.
Right arrow Articles by Zhou, X. N.

The Journal of Immunology, Vol 149, Issue 4 1340-1347, Copyright © 1992 by American Association of Immunologists


ARTICLES

Divalent cation substitution reveals CD18- and very late antigen- dependent pathways that mediate human neutrophil adherence to fibronectin

JF Bohnsack and XN Zhou
Department of Pediatrics and Pathology, University of Utah School of Medicine, Salt Lake City 84132.

We investigated the mechanisms by which Mn2+ alters human neutrophil (PMN) adherence to various connective tissue proteins. Substitution of Mn2+ for Ca2+ and Mg2+ significantly increased adhesion of human PMN to plastic well coated with fibronectin, fibrinogen, and laminin but not gelatin. Anti-CD18 mAb almost completely blocked adherence to laminin, partly blocked adherence to fibrinogen, but did not inhibit adhesion to fibronectin at all. In contrast, anti-very late antigen (VLA)-5 mAb antibodies significantly reduced Mn(2+)-mediated PMN adherence to fibronectin, but not to laminin or fibrinogen, demonstrating that VLA-5- mediated PMN adherence to fibronectin, but not to fibrinogen or laminin. This was supported by experiments in which synthetic GRGDSP peptide significantly inhibited Mn(2+)-mediated adherence to fibronectin, but not to laminin or fibrinogen. Activation of PMN with phorbol ester or C5a stimulated VLA-5-mediated adhesion to fibronectin, but the contribution of VLA-5 to the forces mediating adherence could only be detected when CD18 function was either blocked with mAb, or when CD18 was congenitally absent. VLA-5 mediated adhesion was also more transient than CD18-dependent adhesion. These data further confirm the presence of PMN VLA integrins and demonstrate that PMN VLA-5 contributes to stimulated PMN adherence to fibronectin.


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
V. Elgazar-Carmon, A. Rudich, N. Hadad, and R. Levy
Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding
J. Lipid Res., September 1, 2008; 49(9): 1894 - 1903.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. S. Iyer, R. S. Agrawal, C. R. Thompson, S. Thompson, J. A. Barton, and D. J. Kusner
Phospholipase D1 Regulates Phagocyte Adhesion
J. Immunol., March 15, 2006; 176(6): 3686 - 3696.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. W. Sullivan, D. D. Lee, W. G. Ross, J. A. DiVietro, C. M. Lappas, M. B. Lawrence, and J. Linden
Activation of A2A adenosine receptors inhibits expression of {alpha}4/{beta}1 integrin (very late antigen-4) on stimulated human neutrophils
J. Leukoc. Biol., January 1, 2004; 75(1): 127 - 134.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. A. Ustinov and E. F. Plow
Delineation of the Key Amino Acids Involved in Neutrophil Inhibitory Factor Binding to the I-domain Supports a Mosaic Model for the Capacity of Integrin alpha Mbeta 2 to Recognize Multiple Ligands
J. Biol. Chem., May 17, 2002; 277(21): 18769 - 18776.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Feldhaus, A. S. Weyrich, G. A. Zimmerman, and T. M. McIntyre
Ceramide Generation in Situ Alters Leukocyte Cytoskeletal Organization and beta 2-Integrin Function and Causes Complete Degranulation
J. Biol. Chem., February 1, 2002; 277(6): 4285 - 4293.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Burns, T. B. Issekutz, H. Yagita, and A. C. Issekutz
The {{alpha}}4{{beta}}1 (Very Late Antigen (VLA)-4, CD49d/CD29) and {{alpha}}5{{beta}}1 (VLA-5, CD49e/CD29) Integrins Mediate {{beta}}2 (CD11/CD18) Integrin-Independent Neutrophil Recruitment to Endotoxin-Induced Lung Inflammation
J. Immunol., April 1, 2001; 166(7): 4644 - 4649.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. S. Harris, A. O. Shigeoka, W. Li, R. H. Adams, S. M. Prescott, T. M. McIntyre, G. A. Zimmerman, and D. E. Lorant
A novel syndrome of variant leukocyte adhesion deficiency involving defects in adhesion mediated by {beta}1 and {beta}2 integrins
Blood, February 1, 2001; 97(3): 767 - 776.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Kurosawa, C. T. Esmon, and D. J. Stearns-Kurosawa
The Soluble Endothelial Protein C Receptor Binds to Activated Neutrophils: Involvement of Proteinase-3 and CD11b/CD18
J. Immunol., October 15, 2000; 165(8): 4697 - 4703.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Werr, E. E. Eriksson, P. Hedqvist, and L. Lindbom
Engagement of {beta}2 integrins induces surface expression of {beta}1 integrin receptors in human neutrophils
J. Leukoc. Biol., October 1, 2000; 68(4): 553 - 560.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
G. Asimakopoulos, A. Kohn, D. C. Stefanou, D. O. Haskard, R. C. Landis, and K. M. Taylor
Leukocyte integrin expression in patients undergoing cardiopulmonary bypass
Ann. Thorac. Surg., April 1, 2000; 69(4): 1192 - 1197.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Werr, J. Johansson, E. E. Eriksson, P. Hedqvist, E. Ruoslahti, and L. Lindbom
Integrin alpha 2beta 1 (VLA-2) is a principal receptor used by neutrophils for locomotion in extravascular tissue
Blood, March 1, 2000; 95(5): 1804 - 1809.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Anderson, N. Hotchin, and G. Nash
Role of the cytoskeleton in rapid activation of CD11b/CD18 function and its subsequent downregulation in neutrophils
J. Cell Sci., January 8, 2000; 113(15): 2737 - 2745.
[Abstract] [PDF]


Home page
CVIHome page
B. Zweiman and C. von Allmen
Comparative Effects of Antilactoferrin Antibodies and Tumor Necrosis Factor on Neutrophil Adherence to Matrix Proteins
Clin. Vaccine Immunol., May 1, 1999; 6(3): 364 - 368.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. Andersson, K.-E. Magnusson, M. Majeed, O. Stendahl, and M. Fallman
Yersinia pseudotuberculosis-Induced Calcium Signaling in Neutrophils Is Blocked by the Virulence Effector YopH
Infect. Immun., May 1, 1999; 67(5): 2567 - 2574.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Werr, X. Xie, P. Hedqvist, E. Ruoslahti, and L. Lindbom
{beta}1 Integrins Are Critically Involved in Neutrophil Locomotion in Extravascular Tissue In Vivo
J. Exp. Med., June 15, 1998; 187(12): 2091 - 2096.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. G. DiScipio, P. J. Daffern, I. U. Schraufstatter, and P. Sriramarao
Human Polymorphonuclear Leukocytes Adhere to Complement Factor H Through an Interaction That Involves {alpha}M{beta}2 (CD11b/CD18)
J. Immunol., April 15, 1998; 160(8): 4057 - 4066.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. D. Gresham, I. L. Graham, G. L. Griffin, J.-C. Hsieh, L.-J. Dong, AlbertE. Chung, and RobertM. Senior
Domain-specific Interactions between Entactin and Neutrophil Integrins. G2 DOMAIN LIGATION OF INTEGRIN alpha 3beta 1 AND E DOMAIN LIGATION OF THE LEUKOCYTE RESPONSE INTEGRIN SIGNAL FOR DIFFERENT RESPONSES
J. Biol. Chem., November 29, 1996; 271(48): 30587 - 30594.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Zhang and E. F. Plow
Overlapping, but Not Identical, Sites Are Involved in the Recognition of C3bi, Neutrophil Inhibitory Factor, and Adhesive Ligands by the alpha Mbeta 2 Integrin
J. Biol. Chem., July 26, 1996; 271(30): 18211 - 18216.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.